Gavriliu L C, Benea O E, Benea S
Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania; "Prof. Dr. Matei Bals" National Institute of Infectious Diseases, Bucharest, Romania.
J Med Life. 2016 Oct-Dec;9(4):419-423.
According to the European Antimicrobial Resistance Surveillance Network, Romania reports an increasing number of resistant Klebsiella pneumoniae strains from invasive infections every year. We analyzed the antimicrobial susceptibility of Klebsiella pneumoniae strains isolated from blood in 2010 and 2015 in "Matei Bals" National Institute of Infectious Diseases, in order to identify any significant changes in the last five years. We identified 18 strains in 2010 and 37 strains in 2015. Although the resistance to aminopenicillin-betalactamase inhibitors association, piperacillin-tazobactam, third generation cephalosporins, fluoroquinolones, gentamicin, amikacin and the combined resistance decreased between these two time frames, this evolution was statistically non-significant. The same was noticed for the increased resistance rates to carbapenems. Antimicrobial resistance of Klebsiella pneumoniae may become a major problem for the public health and the hospital-acquired infections control. Therefore, it needs further monitoring and efforts must be made in order to limit the increase of the resistance.
根据欧洲抗菌药物耐药性监测网络的数据,罗马尼亚报告称,每年侵袭性感染中耐药肺炎克雷伯菌菌株的数量都在增加。我们分析了2010年和2015年在“马泰·巴尔什”国家传染病研究所从血液中分离出的肺炎克雷伯菌菌株的药敏情况,以确定过去五年中是否有任何显著变化。我们在2010年鉴定出18株菌株,在2015年鉴定出37株菌株。尽管在这两个时间段之间,对氨基青霉素-β-内酰胺酶抑制剂联合制剂、哌拉西林-他唑巴坦、第三代头孢菌素、氟喹诺酮类、庆大霉素、阿米卡星以及联合耐药性均有所下降,但这种变化在统计学上并不显著。对碳青霉烯类耐药率的上升情况也是如此。肺炎克雷伯菌的抗菌药物耐药性可能会成为公共卫生和医院感染控制的一个主要问题。因此,需要进一步监测,并必须做出努力以限制耐药性的增加。